DaRT Source Radon Release Control for Pancreatic Cancer
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current radiotherapy methods using alpha particles face challenges in delivering sufficient radiation to tumors while minimizing damage to healthy tissues, as the short range of alpha particles limits their therapeutic effectiveness and existing diffusion methods struggle to maintain adequate radon release rates within tumors.
Innovation Solution
The development of diffusing alpha-emitter radiation therapy (DaRT) sources with tailored radon release rates and spatial arrangements, such as hexagonal patterns with specific spacings, to ensure effective tumor coverage and minimize radiation exposure to healthy tissues, using radium-223 or radium-224 atoms to generate alpha particles with controlled diffusion and decay.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If alpha particles are used for radiotherapy, then the destructive effect on tumor cells is enhanced, but the short range limits the therapeutic effectiveness
Solution Approach 1:
The source is segmented into multiple discrete radium atoms distributed throughout the tumor volume, each generating alpha particles that travel short distances. This segmentation allows the tumor to be treated as a collection of localized treatment zones, overcoming the short range limitation by distributing multiple sources throughout the tumor.
Solution Approach 2:
Radon atoms serve as intermediaries that carry the radium's radioactive decay product away from the source into the surrounding tumor tissue. The radon atoms diffuse from the source location, delivering alpha-emitting radionuclides to distant tumor cells while the parent radium remains confined to the source.
2Stability of the object's composition
If radium atoms are attached to the source with sufficient strength to prevent loss, then the source stability is improved, but the daughter radionuclides cannot leave the source to treat surrounding tissue
Solution Approach 1:
The source structure has different local properties: the radium atoms are strongly bound to the source matrix (preventing loss), while the daughter radon atoms are allowed to escape into the tumor tissue. This local differentiation in binding strength enables simultaneous source stability and radon release.
Solution Approach 2:
The binding energy parameter is changed between parent and daughter atoms. Radium atoms are bound with high binding energy to remain on the source, while radon atoms are released with lower binding energy to diffuse into the tumor. This parameter change enables selective retention of parent atoms and release of daughter atoms.
3Reliability
If the source releases too many radon atoms, then the tumor destruction probability increases, but healthy tissue outside the tumor is damaged
Solution Approach 1:
The harmful effect is extracted and localized to the tumor volume by confining the radium sources within the tumor boundaries. The short range of alpha particles ensures that even though radon atoms diffuse throughout the tumor, the alpha radiation does not extend beyond the tumor into healthy tissue.
Solution Approach 2:
The source activity is predetermined and calibrated to release exactly the right amount of radon atoms needed for tumor destruction. By controlling the initial radium activity and radon release rate, the treatment delivers sufficient radiation to destroy the tumor while preventing excessive radon release that would damage healthy tissue.
4Area of stationary object
If conventional radiotherapy is used, then the treatment coverage is extended, but the effectiveness against hypoxic cells is reduced
Solution Approach 1:
The hypoxic conditions that normally protect tumor cells from conventional radiation are converted into a benefit for alpha therapy. Alpha particles create dense ionization tracks that produce complex DNA damage independent of oxygen, turning the hypoxic environment from a protective factor into a condition where alpha particles maintain their full destructive effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for accurately tailored radiation delivery to tumors, increasing the therapeutic range of alpha radiation while minimizing damage to surrounding tissues, ensuring effective tumor destruction with controlled radon release rates and spatial distribution.
Implementation Method 1
radium-223 or radium-224 atoms, which generate chains of several radioactive decays with a governing halflife of 3.6 days for radium-224 and 11.4 days for radium-223
Implementation Method 2
These radionuclides, and their own radioactive daughter atoms, spread around the source by diffusion up to a radial distance of a few millimeters before they decay by alpha emission
Implementation Method 3
These radionuclides, and their own radioactive daughter atoms, spread around the source by diffusion up to a radial distance of a few millimeters before they decay by alpha emission
Data Source
Figure 1
Figure 2
Figure 3~4
AI summary
A diffusing alpha-emitter radiation therapy (DaRT) source for use in treatment of a pancreatic cancer tumor of a patient, the source comprising a support having a length of at least 1 millimeter; and radium-224 atoms coupled to the support such that not more than 20% of the radium-224 atoms leave the support into the tumor in 24 hours, without decay, when the source is implanted in the tumor, but upon decay, at least 5% of daughter radionuclides of the radium-224 atoms leave the support upon decay. The administration pattern of the source comprises implanting the source in the pancreatic cancer tumor throughout the tumor, with a spacing between the sources of between 3-4.5 millimeters, and the radiation therapy source has a radon release rate of between 1.2 and 2.5 microcurie per centimeter length.